Lv3
356 积分 2024-05-28 加入
Equecabtagene Autoleucel in Patients With Relapsed or Refractory Multiple Myeloma
8小时前
求助中
Equecabtagene Autoleucel in Patients With Relapsed or Refractory Multiple Myeloma
6天前
已完结
Equecabtagene Autoleucel in Patients With Relapsed or Refractory Multiple Myeloma
6天前
已完结
Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study
11天前
已完结
Delandistrogene Moxeparvovec: First Approval
12天前
已完结
Safety and Toxicity Profiles of CAR T Cell Therapy in Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis
14天前
已完结
US Food and Drug Administration Approval of Drugs Not Meeting Pivotal Trial Primary End Points, 2018-2021
17天前
已完结
Safety and Efficacy of CT041 in Patients With Refractory Metastatic Pancreatic Cancer: A Pooled Analysis of Two Early-Phase Trials
24天前
已完结
Erratum: Safety and Efficacy of CT041 in Patients With Refractory Metastatic Pancreatic Cancer: A Pooled Analysis of Two Early-Phase Trials
24天前
已关闭
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
24天前
已完结
皖公网安备34019202002308
